Quinoline derivative and quinazoline derivate inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same

Details for Australian Patent Application No. 2002313249 (hide)

Owner Kirin Pharma Kabushiki Kaisha

Inventors Miwa, Atsushi; Senga, Terufumi; Osawa, Tatsushi; Nakamura, Kazuhide; Fujiwara, Yasunari; Nishoba, Tsuyoshi

Agent Davies Collison Cave

Pub. Number AU-B-2002313249

PCT Number PCT/JP02/06239

PCT Pub. Number WO2003/000660

Priority 2001-190238 22.06.01 JP

Filing date 21 June 2002

Wipo publication date 8 January 2003

Acceptance publication date 21 August 2008

International Classifications

C07D 215/233 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/5377 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 215/40 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 239/88 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 2001-190238 22.06.01 JP

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002313249

17 April 2008 Assignment before Grant

  Kirin Beer Kabushiki Kaisha The application has been assigned to Kirin Pharma Kabushiki Kaisha

21 August 2008 Application Accepted

  Published as AU-B-2002313249

18 December 2008 Standard Patent Sealed

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002313250-METAL COORDINATION COMPOUND AND ELECTROLUMINESCENCE DEVICE

2002313248-NITROGENOUS HETEROCYCLIC DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, MEDICINAL USE THEREOF, AND INTERMEDIATE THEREFOR